Barnes Wealth Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Sell
853
-14
-2% -$5.58K 0.16% 128
2026
Q2
$314K Sell
867
-6
-0.7% -$2.05K 0.15% 138
2026
Q1
$307K Sell
873
-6
-0.7% -$2.14K 0.16% 135
2025
Q4
$288K Buy
879
+4
+0.5% +$1.27K 0.15% 132
2025
Q3
$247K Buy
875
+4
+0.5% +$1.16K 0.14% 144
2025
Q2
$243K Buy
871
+43
+5% +$12.2K 0.14% 135
2025
Q1
$258K Buy
828
+56
+7% +$16.5K 0.17% 120
2024
Q4
$201K Buy
+772
New +$229K 0.13% 137

Other funds holding AMGN

Barnes Wealth Management Group's AMGN Position: Q3 2026 in Review

Barnes Wealth Management Group reduced its Amgen (AMGN) stake by 1.6% in Q3 2026, selling an estimated $5.58K and leaving 853 shares worth $360K. The position accounts for 0.16% of the portfolio, ranked #128.

Barnes Wealth Management Group first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Barnes Wealth Management Group held 853 shares of Amgen worth $360K as of Q3 2026.
  • Barnes Wealth Management Group sold 14 Amgen shares in Q3 2026, an estimated $5.58K.
  • Amgen made up 0.16% of Barnes Wealth Management Group's portfolio in Q3 2026, its #128 holding.
  • Barnes Wealth Management Group first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Barnes Wealth Management Group's 13F filing for Q3 2026, filed 9 Nov 2026.